BACKGROUND: Although the Mediterranean diet has been studied for cancer mortality and the Dietary Approaches to Stop Hypertension (DASH) diet shares similarities with the Mediterranean diet, few studies have specifically examined these 2 diets and incident colorectal cancer. OBJECTIVE: The objective was to prospectively assess the association between the Alternate Mediterranean Diet (aMed) and the DASH-style diet scores and risk of colorectal cancer in middle-aged men and women. DESIGN: A total of 87,256 women and 45,490 men (age 30-55 y for women and 40-75 y for men at baseline) without a history of cancer were followed for ≤ 26 y. The aMed and DASH scores were calculated for each participant by using dietary information that was assessed ≤ 7 times during follow-up. Relative risks (RRs) for colorectal cancer were computed with adjustment for potential confounders. RESULTS: We documented 1432 cases of incident colorectal cancer among women and 1032 cases in men. Comparing top with bottom quintiles of the DASH score, the pooled RR for total colorectal cancer was 0.80 (95% CI: 0.70, 0.91; P for trend = 0.0001). The corresponding RR for DASH score and colon cancer was 0.81 (95% CI: 0.69, 0.95; P for trend = 0.002). There was a suggestion of an inverse association with rectal cancer with a pooled RR of 0.73 (95% CI: 0.55, 0.98; P for trend = 0.31) when comparing top with bottom quintiles of DASH score. No association was observed with aMed score. CONCLUSION: Adherence to the DASH diet (which involves higher intakes of whole grains, fruit, and vegetables; moderate amounts of low-fat dairy; and lower amounts of red or processed meats, desserts, and sweetened beverages) was associated with a lower risk of colorectal cancer.
BACKGROUND: Although the Mediterranean diet has been studied for cancer mortality and the Dietary Approaches to Stop Hypertension (DASH) diet shares similarities with the Mediterranean diet, few studies have specifically examined these 2 diets and incident colorectal cancer. OBJECTIVE: The objective was to prospectively assess the association between the Alternate Mediterranean Diet (aMed) and the DASH-style diet scores and risk of colorectal cancer in middle-aged men and women. DESIGN: A total of 87,256 women and 45,490 men (age 30-55 y for women and 40-75 y for men at baseline) without a history of cancer were followed for ≤ 26 y. The aMed and DASH scores were calculated for each participant by using dietary information that was assessed ≤ 7 times during follow-up. Relative risks (RRs) for colorectal cancer were computed with adjustment for potential confounders. RESULTS: We documented 1432 cases of incident colorectal cancer among women and 1032 cases in men. Comparing top with bottom quintiles of the DASH score, the pooled RR for total colorectal cancer was 0.80 (95% CI: 0.70, 0.91; P for trend = 0.0001). The corresponding RR for DASH score and colon cancer was 0.81 (95% CI: 0.69, 0.95; P for trend = 0.002). There was a suggestion of an inverse association with rectal cancer with a pooled RR of 0.73 (95% CI: 0.55, 0.98; P for trend = 0.31) when comparing top with bottom quintiles of DASH score. No association was observed with aMed score. CONCLUSION: Adherence to the DASH diet (which involves higher intakes of whole grains, fruit, and vegetables; moderate amounts of low-fat dairy; and lower amounts of red or processed meats, desserts, and sweetened beverages) was associated with a lower risk of colorectal cancer.
Authors: B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon Journal: Med Sci Sports Exerc Date: 2000-09 Impact factor: 5.411
Authors: W C Willett; F Sacks; A Trichopoulou; G Drescher; A Ferro-Luzzi; E Helsing; D Trichopoulos Journal: Am J Clin Nutr Date: 1995-06 Impact factor: 7.045
Authors: F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245
Authors: S Salvini; D J Hunter; L Sampson; M J Stampfer; G A Colditz; B Rosner; W C Willett Journal: Int J Epidemiol Date: 1989-12 Impact factor: 7.196
Authors: G A Colditz; P Martin; M J Stampfer; W C Willett; L Sampson; B Rosner; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1986-05 Impact factor: 4.897
Authors: Angela D Liese; Michele Nichols; Xuezheng Sun; Ralph B D'Agostino; Steven M Haffner Journal: Diabetes Care Date: 2009-06-01 Impact factor: 19.112
Authors: Teresa T Fung; Frank B Hu; Susan E Hankinson; Walter C Willett; Michelle D Holmes Journal: Am J Epidemiol Date: 2011-08-10 Impact factor: 4.897
Authors: Cemal Yazici; Patricia G Wolf; Hajwa Kim; Tzu-Wen L Cross; Karin Vermillion; Timothy Carroll; Gaius J Augustus; Ece Mutlu; Lisa Tussing-Humphreys; Carol Braunschweig; Rosa M Xicola; Barbara Jung; Xavier Llor; Nathan A Ellis; H Rex Gaskins Journal: Gut Date: 2017-02-02 Impact factor: 23.059
Authors: Xiaosheng He; Kana Wu; Xuehong Zhang; Reiko Nishihara; Yin Cao; Charlie S Fuchs; Edward L Giovannucci; Shuji Ogino; Andrew T Chan; Mingyang Song Journal: Int J Cancer Date: 2019-05-21 Impact factor: 7.396
Authors: James A Blumenthal; Patrick J Smith; Stephanie Mabe; Alan Hinderliter; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Pao-Hwa Lin; William Kraus; P Murali Doraiswamy; James Burke; Andrew Sherwood Journal: Psychosom Med Date: 2017 Jul/Aug Impact factor: 4.312
Authors: Joshua Petimar; Stephanie A Smith-Warner; Teresa T Fung; Bernard Rosner; Andrew T Chan; Frank B Hu; Edward L Giovannucci; Fred K Tabung Journal: Am J Clin Nutr Date: 2018-11-01 Impact factor: 7.045
Authors: Amy M Sheflin; Erica C Borresen; Jay S Kirkwood; Claudia M Boot; Alyssa K Whitney; Shen Lu; Regina J Brown; Corey D Broeckling; Elizabeth P Ryan; Tiffany L Weir Journal: Mol Nutr Food Res Date: 2016-09-12 Impact factor: 5.914